Schöfl R
Dept. of Gastroenterology and Hepatology, University of Vienna, Austria.
Endoscopy. 2001 Feb;33(2):147-57. doi: 10.1055/s-2001-11667.
Since the introduction of magnetic resonance cholangiopancreatography (MRCP), the focus in endoscopic retrograde cholangiopancreatography (ERCP) has shifted from diagnosis to treatment - a change that has organizational implications in relation to teaching and providing access to ERCP. Most of last year's papers on ERCP described refinements of the technique and indication, tissue sampling, and efforts to reduce complications. Many studies compared MRCP with various other imaging methods and with histopathological findings. Bile duct stones and strictures are still the main target, but new entities for evaluation with MRCP have been found: primary sclerosing cholangitis, choledochal cysts, chronic pancreatitis, pancreatic injury, and postoperative abnormalities. Helical computed-tomographic cholangiography is still attracting some interest. This review closes with a comparison of ERCP with MRCP with regard to availability, legal aspects, operator-dependency, and cost-effectiveness.
自从磁共振胰胆管造影（MRCP）问世以来，内镜逆行胰胆管造影（ERCP）的重点已从诊断转向治疗——这一变化在教学和提供ERCP途径方面具有组织层面的影响。去年关于ERCP的大多数论文描述了该技术及适应证的改进、组织采样以及减少并发症的努力。许多研究将MRCP与其他各种成像方法以及组织病理学结果进行了比较。胆管结石和狭窄仍然是主要目标，但已发现了可通过MRCP评估的新病种：原发性硬化性胆管炎、胆总管囊肿、慢性胰腺炎、胰腺损伤及术后异常。螺旋计算机断层扫描胆管造影仍受到一些关注。本文最后比较了ERCP与MRCP在可及性、法律层面、操作者依赖性和成本效益方面的情况。
